{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:22Z","timestamp":1793724262487,"version":"4.6.1"},"reference-count":231,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The development of endometrial cancer is a gradual malignant transformation process driven by multiple factors, and the immune microenvironment is closely related to clinical outcomes and immunotherapy responses. Under physiological conditions, the immune microenvironment of the normal endometrium undergoes periodic reshaping under the regulation of estrogen and progesterone, maintaining the balance between immune defense and reproductive capacity. However, continuous exposure to risk factors, such as non-antagonistic estrogen, may trigger endometrial intraepithelial neoplasia. During this period, the immune microenvironment becomes dysregulated, supporting malignant progression. For example, estrogen-stimulated interactions between endothelial cells and macrophages, elevated neutrophil\/lymphocyte ratios, and the accumulation of regulatory T cells all combine to cause dysregulation of immune microenvironment. The abnormal immune microenvironment that occurs in the precancerous lesion stage interacts with systemic and genetic carcinogenic factors, ultimately shaping the unique immune microenvironment of each molecular subtype of endometrial cancer. POLE-mutated and MSI-H subtype endometrial cancer are immune-infiltrated tumors, whereas the copy-number high subtype is immune-suppressive tumor and the copy-number low subtype is immune-desert tumor. However, still little is known about the immune dysregulation that occurs during the precancerous stage and its impact on subsequent malignant progression. This review systematically describes the changes in the immune microenvironment during the process from normal endometrium to endometrial cancer, emphasizing that endometrial intraepithelial neoplasia is a key stage of immune imbalance, thus paving the way for early immune intervention and precise immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1749138","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:32:22Z","timestamp":1770013942000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The dysregulation of the immune microenvironment during endometrial intraepithelial neoplasia serves as a marker of endometrial carcinogenesis"],"prefix":"10.3389","volume":"17","author":[{"given":"Yingying","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglei","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minqi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejun","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfen","family":"An","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, The First Affiliated Hospital of Anhui Medical University","place":["Hefei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Clinical Research Center of Cancer Immunotherapy","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","article-title":"Endometrial cancer","volume-title":"StatPearls","author":"Mahdy","year":"2025"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.4638","article-title":"Addressing the role of obesity in endometrial cancer risk, prevention, and treatment","volume":"34","author":"Onstad","year":"2016","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005814","article-title":"Associated trends in obesity and endometrioid endometrial cancer in the United States","volume":"145","author":"Francoeur","year":"2025","journal-title":"Obstet Gynecol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21561","article-title":"Current recommendations and recent progress in endometrial cancer","volume":"69","author":"Brooks","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2021.12.001","article-title":"Histopathologic diagnosis of endometrial precancers: Updates and future directions","volume":"39","author":"Chen","year":"2022","journal-title":"Semin Diagn Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050914","article-title":"Atypical endometrial hyperplasia and concurrent cancer: A comprehensive overview on a challenging clinical condition","volume":"16","author":"Giannella","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2010.09.007","article-title":"Endometrial intraepithelial neoplasia","volume":"27","author":"Jarboe","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21058","article-title":"The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system","volume":"103","author":"Baak","year":"2005","journal-title":"Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071681","article-title":"Dual effect of immune cells within tumour microenvironment: pro- and anti-tumour effects and their triggers","volume":"14","author":"Pe\u00f1a-Romero","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"6300","DOI":"10.1038\/s41467-022-33982-7","article-title":"Single-cell transcriptomic analysis highlights origin and pathological process of human endometrioid endometrial carcinoma","volume":"13","author":"Ren","year":"2022","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0950-3552(89)80023-9","article-title":"The immune function of the endometrium","volume":"3","author":"Lea","year":"1989","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5653\/cerm.2011.38.3.119","article-title":"Role of endometrial immune cells in implantation","volume":"38","author":"Lee","year":"2011","journal-title":"Clin Exp Reprod Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.918550","article-title":"Uterine natural killer cells: A rising star in human pregnancy regulation","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.66","article-title":"Human dNK cell function is differentially regulated by extrinsic cellular engagement and intrinsic activating receptors in first and second trimester pregnancy","volume":"14","author":"Zhang","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00739-z","article-title":"Biology and pathology of the uterine microenvironment and its natural killer cells","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/PAT.0b013e328361429b","article-title":"The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. III: Further observations and reference ranges","volume":"45","author":"Russell","year":"2013","journal-title":"Pathology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abb7800","article-title":"Continuous human uterine NK cell differentiation in response to endometrial regeneration and pregnancy","volume":"6","author":"Strunz","year":"2021","journal-title":"Sci Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2009.02.030","article-title":"The developmental role of natural killer cells at the fetal-maternal interface","volume":"201","author":"Yagel","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901435","article-title":"Human term pregnancy decidual NK cells generate distinct cytotoxic responses","volume":"204","author":"de Mendon\u00e7a Vieira","year":"2020","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00467","article-title":"Uterine natural killer cells: functional distinctions and influence on pregnancy in humans and mice","volume":"8","author":"Gaynor","year":"2017","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-025-01392-6","article-title":"Macrophages: a double-edged sword in female reproduction and disorders","volume":"57","author":"Park","year":"2025","journal-title":"Exp Mol Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1997.tb00311.x","article-title":"Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina","volume":"38","author":"Givan","year":"1997","journal-title":"Am J Reprod Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01873-w","article-title":"An integrated single-cell reference atlas of the human endometrium","volume":"56","author":"Mare\u010dkov\u00e1","year":"2024","journal-title":"Nat Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1242\/dev.199577","article-title":"Cyclical endometrial repair and regeneration","volume":"148","author":"Salamonsen","year":"2021","journal-title":"Development"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1364036","article-title":"Uterine macrophages and NK cells exhibit population and gene-level changes after implantation but maintain pro-invasive properties","volume":"15","author":"Mani","year":"2024","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsgi.2004.05.007","article-title":"Antigen-presenting cells in human endometrium during the menstrual cycle compared to early pregnancy","volume":"11","author":"Rieger","year":"2004","journal-title":"J Soc Gynecol Investig"},{"key":"B31","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0008-8749(84)90262-4","article-title":"Macrophages in murine uterus are immunosuppressive","volume":"85","author":"Hunt","year":"1984","journal-title":"Cell Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.607328","article-title":"Macrophage plasticity in reproduction and environmental influences on their function","volume":"11","author":"Chambers","year":"2020","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2019.89610","article-title":"Comparison of T and NK lymphocyte subsets between human endometrial tissue and peripheral blood","volume":"44","author":"Chernyshov","year":"2019","journal-title":"Cent Eur J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-0378(99)00002-9","article-title":"Menstruation: induction by matrix metalloproteinases and inflammatory cells","volume":"44","author":"Salamonsen","year":"1999","journal-title":"J Reprod Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/aji.12182","article-title":"Phenotype and functionality of CD4+ and CD8+ T cells in the upper reproductive tract of healthy premenopausal women","volume":"71","author":"Shanmugasundaram","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/humupd\/6.1.16","article-title":"Endometrial leukocytes and menstruation","volume":"6","author":"Salamonsen","year":"2000","journal-title":"Hum Reprod Update"},{"key":"B37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4110\/in.2015.15.1.16","article-title":"Immune cells in the female reproductive tract","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.64","article-title":"The unique immunological and microbial aspects of pregnancy","volume":"17","author":"Mor","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01023","article-title":"Role of regulatory T cells in regulating fetal-maternal immune tolerance in healthy pregnancies and reproductive diseases","volume":"11","author":"Huang","year":"2020","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(11)91568-3","article-title":"Endometrial lymphoid tissue in the timed endometrial biopsy: morphometric and immunohistochemical aspects","volume":"167","author":"Klentzeris","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"hoab043","DOI":"10.1093\/hropen\/hoab043","article-title":"The role of endometrial B cells in normal endometrium and benign female reproductive pathologies: a systematic review","volume":"2022","author":"Shen","year":"2022","journal-title":"Hum Reprod Open"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/den030","article-title":"Endometrial dendritic cell populations during the normal menstrual cycle","volume":"23","author":"Schulke","year":"2008","journal-title":"Hum Reprod"},{"key":"B43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5301\/je.5000180","article-title":"Peripheral and endometrial dendritic cell populations during the normal cycle and in the presence of endometriosis","volume":"6","author":"Maridas","year":"2014","journal-title":"J Endometr Pelvic Pain Disord"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12958-023-01058-w","article-title":"Features of peritoneal dendritic cells in the development of endometriosis","volume":"21","author":"Qiaomei","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113382","article-title":"Immune tolerance of embryo implantation and pregnancy: the role of human decidual stromal cell- and embryonic-derived extracellular vesicles","volume":"23","author":"Wu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02281-0","article-title":"Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity","volume":"23","author":"Lutz","year":"2002","journal-title":"Trends Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(00)00564-9","article-title":"Mast cell distribution and density in the normal uterus--metachromatic staining using lectins","volume":"98","author":"Sivridis","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"667","DOI":"10.12688\/f1000research.11432.2","article-title":"Immunoprofiling of human uterine mast cells identifies three phenotypes and expression of ER\u03b2 and glucocorticoid receptor","volume":"6","author":"De Leo","year":"2017","journal-title":"F1000Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0378(02)00011-6","article-title":"Leukocyte networks and human endometrial remodelling","volume":"57","author":"Salamonsen","year":"2002","journal-title":"J Reprod Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2004.12.003","article-title":"Human endometrial epithelial cells cyclically express Toll-like receptor 3 (TLR3) and exhibit TLR3-dependent responses to dsRNA","volume":"66","author":"Jorgenson","year":"2005","journal-title":"Hum Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012906","article-title":"Toll-like receptor 4 mediates the response of epithelial and stromal cells to lipopolysaccharide in the endometrium","volume":"5","author":"Sheldon","year":"2010","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(00)00149-7","article-title":"MHC class II expression and antigen presentation by human endometrial cells","volume":"76","author":"Wallace","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"101442","DOI":"10.1016\/j.gendis.2024.101442","article-title":"Molecular mechanism of tumor-infiltrating immune cells regulating endometrial carcinoma","volume":"12","author":"Ding","year":"2025","journal-title":"Genes Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12252","article-title":"Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens","volume":"72","author":"Wira","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2001.01199.x","article-title":"CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking","volume":"102","author":"Yeaman","year":"2001","journal-title":"Immunology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02387","article-title":"Uterine immunity and microbiota: A shifting paradigm","volume":"10","author":"Agostinis","year":"2019","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1507\/endocrj.K08E-067","article-title":"Molecular and cellular mechanisms for differentiation and regeneration of the uterine endometrium","volume":"55","author":"Maruyama","year":"2008","journal-title":"Endocr J"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.975201","article-title":"Importance of the endometrial immune environment in endometrial cancer and associated therapies","volume":"12","author":"van der Woude","year":"2022","journal-title":"Front Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/cells13151236","article-title":"Unraveling the dynamics of estrogen and progesterone signaling in the endometrium: an overview","volume":"13","author":"Dias Da Silva","year":"2024","journal-title":"Cells"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00031.2019","article-title":"Physiology of the endometrium and regulation of menstruation","volume":"100","author":"Critchley","year":"2020","journal-title":"Physiol Rev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2004.10.007","article-title":"Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations","volume":"97","author":"Phiel","year":"2005","journal-title":"Immunol Lett"},{"key":"B62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tem.2005.01.004","article-title":"Transcription factor cross-talk: the estrogen receptor and NF-kappaB","volume":"16","author":"Kalaitzidis","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1303400","article-title":"X-Chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-mediated IFN-\u03b1 production of plasmacytoid dendritic cells from women","volume":"193","author":"Laffont","year":"2014","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2015.01.018","article-title":"Estrogen receptors regulate innate immune cells and signaling pathways","volume":"294","author":"Kovats","year":"2015","journal-title":"Cell Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-236935","article-title":"Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4","volume":"115","author":"Carreras","year":"2010","journal-title":"Blood"},{"key":"B66","article-title":"Anatomy, abdomen and pelvis, ovary corpus luteum","volume-title":"StatPearls","author":"Oliver","year":"2025"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.plabm.2021.e00211","article-title":"Extensive monitoring of the natural menstrual cycle using the serum biomarkers estradiol, luteinizing hormone and progesterone","volume":"25","author":"Anckaert","year":"2021","journal-title":"Pract Lab Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1012491","article-title":"The intracellular progesterone receptor regulates CD4+ T cells and T cell-dependent antibody responses","volume":"93","author":"Hughes","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445404","article-title":"Progesterone promotes maternal-fetal tolerance by reducing human maternal T-cell polyfunctionality and inducing a","volume":"45","author":"Lissauer","year":"2015","journal-title":"specific Cytokine profile. Eur J Immunol"},{"key":"B70","article-title":"Premalignant lesions of the endometrium","volume-title":"StatPearls","author":"Pandey","year":"2025"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1396256","article-title":"New WHO classification of endometrial hyperplasias","volume":"75","author":"Emons","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.1995.05030233.x","article-title":"Endometrial hyperplasia and the risk of carcinoma","volume":"5","author":"Widra","year":"1995","journal-title":"Int J Gynecol Cancer"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2018.1540886","article-title":"The role of biomarkers in endometrial cancer and hyperplasia: a literature review","volume":"58","author":"Hutt","year":"2019","journal-title":"Acta Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14222471","article-title":"Endometrial atypical hyperplasia and risk of endometrial cancer","volume":"14","author":"Chou","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20210318","article-title":"Comparison of nonspecific inflammatory markers in endometrial cancer and hyperplasia","volume":"67","author":"Alper","year":"2021","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-019-05372-w","article-title":"Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis","volume":"301","author":"Ni","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13295","article-title":"Changes in subsets of immunocytes in endometrial hyperplasia","volume":"84","author":"Lai","year":"2020","journal-title":"Am J Reprod Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.humpath.2009.06.012","article-title":"Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins","volume":"41","author":"Witkiewicz","year":"2010","journal-title":"Hum Pathol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403038","article-title":"SHP2-triggered endothelial cell activation fuels estradiol-independent endometrial sterile inflammation","volume":"11","author":"Pan","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e53","article-title":"PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia","volume":"34","author":"Xue","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101458","article-title":"PTEN and gynecological cancers","volume":"11","author":"Nero","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/cells14010058","article-title":"The estrogen-immune interface in endometriosis","volume":"14","author":"Greygoose","year":"2025","journal-title":"Cells"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S335924","article-title":"Correlation of metabolic factors with endometrial atypical hyperplasia and endometrial cancer: development and assessment of a new predictive nomogram","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancer Manage Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.e17622","article-title":"Molecular classification of endometrial carcinoma applied to endometrial atypical hyperplasia biopsy specimens","volume":"40","author":"Corey","year":"2022","journal-title":"J Clin Oncol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41419-024-06960-8","article-title":"Single-cell transcriptome profiles the heterogeneity of tumor cells and microenvironments for different pathological endometrial cancer and identifies specific sensitive drugs","volume":"15","author":"Ren","year":"2024","journal-title":"Cell Death Dis"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1213347","article-title":"The role of tumor-associated macrophages in the progression, prognosis and treatment of endometrial cancer","volume":"13","author":"Sun","year":"2023","journal-title":"Front Oncol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.657326","article-title":"Endometrial cancer suppresses CD8+ T cell-mediated cytotoxicity in postmenopausal women","volume":"12","author":"Patel","year":"2021","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-03093-1","article-title":"Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer","volume":"71","author":"Qin","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20202321","article-title":"The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer","volume":"41","author":"Liu","year":"2021","journal-title":"Biosci Rep"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16371","article-title":"CXCL9 and CXCL13 shape endometrial cancer immune-activated microenvironment via tertiary lymphoid structure formation","volume":"116","author":"Nagase","year":"2025","journal-title":"Cancer Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031933","article-title":"Distribution of DC subtypes: CD83+, DC-LAMP+, CD1a+, CD1c+, CD123+, and DC-SIGN+ in the tumor microenvironment of endometrial cancers-correlation with clinicopathologic features","volume":"24","author":"Dyduch","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jri.2014.12.006","article-title":"The immune system in the normal endometrium and implications for endometrial cancer development","volume":"109","author":"Vanderstraeten","year":"2015","journal-title":"J Reprod Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-014-1537-8","article-title":"Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy","volume":"63","author":"Vanderstraeten","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41467-022-29040-x","article-title":"Tertiary lymphoid structures critical for prognosis in endometrial cancer patients","volume":"13","author":"Horeweg","year":"2022","journal-title":"Nat Commun"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1198944","article-title":"Exploring the role of macrophages in the progression from atypical hyperplasia to endometrial carcinoma through single-cell transcriptomics and bulk transcriptomics analysis","volume":"14","author":"Song","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.03.039","article-title":"B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration","volume":"106","author":"Miyatake","year":"2007","journal-title":"Gynecol Oncol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.62347\/BXZM8857","article-title":"Immune cell infiltration as a prognostic factor in endometrial cancer: a meta-analysis","volume":"15","author":"Lin","year":"2025","journal-title":"Am J Cancer Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00930-7","article-title":"Prognostic implications of tumor-infiltrating T cells in early-stage endometrial cancer","volume":"35","author":"Mendiola","year":"2022","journal-title":"Modern Pathol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1805764","DOI":"10.1155\/2020\/1805764","article-title":"Tissue infiltrating immune cells as prognostic biomarkers in endometrial cancer: A meta-analysis","volume":"2020","author":"Guo","year":"2020","journal-title":"Dis Markers"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038129","article-title":"Association between immune cells and endometrial cancer: A bidirectional Mendelian randomization study","volume":"103","author":"Zou","year":"2024","journal-title":"Med (Baltimore)"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-022-00708-2","article-title":"Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells","volume":"45","author":"Kolben","year":"2022","journal-title":"Cell Oncol (Dordr)"},{"key":"B102","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.04.004","article-title":"The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy","volume":"10","author":"Yang","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101220-015603","article-title":"B cell function in the tumor microenvironment","volume":"40","author":"Downs-Canner","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"101406","DOI":"10.1016\/j.smim.2020.101406","article-title":"Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer","volume":"48","author":"Saut\u00e8s-Fridman","year":"2020","journal-title":"Semin Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2014.09.006","article-title":"Tertiary lymphoid structures in cancer and beyond","volume":"35","author":"Dieu-Nosjean","year":"2014","journal-title":"Trends Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34035","article-title":"L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma","volume":"151","author":"Romani","year":"2022","journal-title":"Int J Cancer"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4","article-title":"CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells","volume":"31","author":"Jacobs","year":"2001","journal-title":"Eur J Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0979-8","article-title":"Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction","volume":"567","author":"Liu","year":"2019","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e37555","DOI":"10.1097\/MD.0000000000037555","article-title":"Single-cell transcriptomics reveals comprehensive microenvironment and highlights the dysfuntional state of NK cells in endometrioid carcinoma","volume":"103","author":"Shi","year":"2024","journal-title":"Med (Baltimore)"},{"key":"B111","doi-asserted-by":"publisher","first-page":"103306","DOI":"10.1016\/j.critrevonc.2021.103306","article-title":"Immune checkpoint inhibitors in endometrial cancer","volume":"161","author":"G\u00f3mez-Raposo","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2007.06.014","article-title":"HLA-G and cancer","volume":"17","author":"Carosella","year":"2007","journal-title":"Semin Cancer Biol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002899","article-title":"Deregulation of HLA-I in cancer and its central importance for immunotherapy","volume":"9","author":"Hazini","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B114","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2021.12.031","article-title":"LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer","volume":"529","author":"Zhan","year":"2022","journal-title":"Cancer Lett"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2020.03.008","article-title":"Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer","volume":"81","author":"Ben Yahia","year":"2020","journal-title":"Hum Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.05.034","article-title":"Prognostic role of indoleamine 2, 3-dioxygenase in endometrial carcinoma","volume":"126","author":"de Jong","year":"2012","journal-title":"Gynecologic Oncol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in regulatory T cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity"},{"key":"B118","doi-asserted-by":"publisher","first-page":"153990","DOI":"10.1016\/j.prp.2022.153990","article-title":"Analysis of the immune checkpoint lymphocyte activation gene-3 (LAG-3) in endometrial cancer: An emerging target for immunotherapy","volume":"236","author":"Zhang","year":"2022","journal-title":"Pathol - Res Pract"},{"key":"B119","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S445055","article-title":"The clinical and pathological characteristics of POLE-mutated endometrial cancer: A comprehensive review","volume":"16","author":"Yao","year":"2024","journal-title":"Cancer Manag Res"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2023.10.013","article-title":"Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues","volume":"56","author":"Wong","year":"2024","journal-title":"Pathology"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/path.5081","article-title":"Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response","volume":"245","author":"Temko","year":"2018","journal-title":"J Pathol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33516","article-title":"Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis","volume":"127","author":"McAlpine","year":"2021","journal-title":"Cancer"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214318","article-title":"Phenotype of POLE-mutated endometrial cancer","volume":"14","author":"Imboden","year":"2019","journal-title":"PloS One"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3241","article-title":"Molecular subtype not immune response drives outcomes in endometrial carcinoma","volume":"25","author":"Talhouk","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12935-019-1091-8","article-title":"Microsatellite instability: a review of what the oncologist should know","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B127","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-021-00301-z","article-title":"Immunotherapy in endometrial cancer: rationale, practice and perspectives","volume":"9","author":"Cao","year":"2021","journal-title":"biomark Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.2151","article-title":"Association of polymerase e-mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1","volume":"1","author":"Howitt","year":"2015","journal-title":"JAMA Oncol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.06.008","article-title":"Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy","volume":"48","author":"Gargiulo","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1264565","article-title":"Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition","volume":"6","author":"Eggink","year":"2017","journal-title":"Oncoimmunology"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003777","article-title":"Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient\/microsatellite instability-high (dMMR\/MSI-H) or proficient\/stable (MMRp\/MSS) endometrial cancer: interim results from GARNET--a phase I, single-arm study","volume":"10","author":"Ana","year":"2022","journal-title":"J ImmunoTherapy Cancer"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1035616","article-title":"Tumor immune microenvironment in endometrial cancer of different molecular subtypes: evidence from a retrospective observational study","volume":"13","author":"Dai","year":"2022","journal-title":"Front Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009143","article-title":"Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer","volume":"12","author":"Juan Francisco Grau","year":"2024","journal-title":"J ImmunoTherapy Cancer"},{"key":"B134","doi-asserted-by":"publisher","first-page":"115320","DOI":"10.1016\/j.ejca.2025.115320","article-title":"Differences in immunogenicity of TP53-mutated cancers with low tumor mutational burden (TMB) A study on TP53mut endometrial-, ovarian- and triple-negative breast cancer","volume":"219","author":"Steger","year":"2025","journal-title":"Eur J Cancer"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4436","article-title":"Clinicopathologic and genomic analysis of TP53-mutated endometrial carcinomas","volume":"27","author":"Momeni-Boroujeni","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B136","article-title":"Distinct chromosomal imbalances in uterine serous and endometrioid carcinomas","volume":"58","author":"Pere","year":"1998","journal-title":"Cancer Res"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.0120","article-title":"p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes","volume":"61","author":"Zheng","year":"1996","journal-title":"Gynecol Oncol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.35","article-title":"The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium","volume":"26","author":"Fadare","year":"2013","journal-title":"Mod Pathol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1817339","DOI":"10.1155\/2022\/1817339","article-title":"Significance of TP53 mutational status-associated signature in the progression and prognosis of endometrial carcinoma","volume":"2022","author":"Chen","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0546","article-title":"Molecular characterization of endometrial carcinomas in black and white patients reveals disparate drivers with therapeutic implications","volume":"13","author":"Weigelt","year":"2023","journal-title":"Cancer Discov"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001020","article-title":"Molecular classification of grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups","volume":"42","author":"Bosse","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.gocm.2023.01.011","article-title":"Molecular typing guiding treatment and prognosis of endometrial cancer","volume":"3","author":"Junya","year":"2023","journal-title":"Gynecology Obstetrics Clin Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12957-023-03229-w","article-title":"Re-stratification of patients with copy-number low endometrial cancer by clinicopathological characteristics","volume":"21","author":"Liwei","year":"2023","journal-title":"World J Surg Oncol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","article-title":"Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies","volume":"13","author":"Zheng","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235968","article-title":"Tertiary lymphoid structures: A potential biomarker for anti-cancer therapy","volume":"14","author":"Zou","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1616904","article-title":"The pivotal role of tertiary lymphoid structures in the tumor immune microenvironment","volume":"15","author":"Liu","year":"2025","journal-title":"Front Oncol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B148","doi-asserted-by":"publisher","first-page":"21530","DOI":"10.1038\/s41598-020-78560-3","article-title":"Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"B149","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00262-024-03929-6","article-title":"Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancer","volume":"74","author":"Suzuki","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B150","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/jnci\/dju402","article-title":"Prognostic significance of POLE proofreading mutations in endometrial cancer","volume":"107","author":"Church","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt131","article-title":"DNA polymerase \u03f5 and \u03b4 exonuclease domain mutations in endometrial cancer","volume":"22","author":"Church","year":"2013","journal-title":"Hum Mol Genet"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1369189","article-title":"The game-changing impact of POLE mutations in oncology-a review from a gynecologic oncology perspective","volume":"14","author":"K\u00f6gl","year":"2024","journal-title":"Front Oncol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0057","article-title":"POLE proofreading mutations elicit an antitumor immune response in endometrial cancer","volume":"21","author":"van Gool","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1250558","article-title":"Immune signatures of the POLE mutation in endometrial carcinomas: a systematic study based on TCGA data and clinical cohort validation","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/cncr.31901","article-title":"Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker","volume":"125","author":"Backes","year":"2019","journal-title":"Cancer"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9060632","article-title":"Endometrial carcinoma: immune microenvironment and emerging treatments in immuno-oncology","volume":"9","author":"Rousset-Rouviere","year":"2021","journal-title":"Biomedicines"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35030","article-title":"Characterization of mismatch-repair\/microsatellite instability-discordant endometrial cancers","volume":"130","author":"Riedinger","year":"2024","journal-title":"Cancer"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002797","article-title":"Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors","volume":"9","author":"Hwang","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/s41467-018-04002-4","article-title":"Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair","volume":"9","author":"Haradhvala","year":"2018","journal-title":"Nat Commun"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16173069","article-title":"TP53 mutation-mediated immune evasion in cancer: mechanisms and therapeutic implications","volume":"16","author":"Wang","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B163","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/PGP.0000000000000243","article-title":"TP53 mutational spectrum in endometrioid and serous endometrial cancers","volume":"35","author":"Schultheis","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-015-0666-5","article-title":"PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors","volume":"26","author":"Yang","year":"2015","journal-title":"Cancer Causes Control"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0149","article-title":"Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer","volume":"70","author":"Monte","year":"2010","journal-title":"Cancer Res"},{"key":"B166","doi-asserted-by":"publisher","first-page":"139087","DOI":"10.1155\/2010\/139087","article-title":"The synergistic effect of conditional pten loss and oncogenic K-ras mutation on endometrial cancer development occurs via decreased progesterone receptor action","author":"Kim","year":"2010","journal-title":"J Oncol 2010"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2007.09.020","article-title":"Novel molecular profiles of endometrial cancer\u2014new light through old windows","volume":"108","author":"Doll","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3390\/genes11070719","article-title":"PTEN alterations and their role in cancer management: are we making headway on precision medicine","volume":"11","author":"Fusco","year":"2020","journal-title":"Genes (Basel)"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0834-6","article-title":"Emerging role of PTEN loss in evasion of the immune response to tumours","volume":"122","author":"Vidotto","year":"2020","journal-title":"Br J Cancer"},{"key":"B171","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1038\/s41598-023-31759-6","article-title":"Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome","volume":"13","author":"Vidotto","year":"2023","journal-title":"Sci Rep"},{"key":"B172","article-title":"Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma","volume":"53","author":"Sasaki","year":"1993","journal-title":"Cancer Res"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13145","article-title":"The role of KRAS in endometrial cancer: A mini-review","volume":"39","author":"Sideris","year":"2019","journal-title":"Anticancer Res"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1609906","DOI":"10.3389\/pore.2021.1609906","article-title":"The advance and correlation of KRAS mutation with the fertility-preservation treatment of endometrial cancer in the background of molecular classification application","volume":"27","author":"Yu","year":"2021","journal-title":"Pathol Oncol Res"},{"key":"B175","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/cancers17050785","article-title":"KRAS mutations in cancer: understanding signaling pathways to immune regulation and the potential of immunotherapy","volume":"17","author":"Uniyal","year":"2025","journal-title":"Cancers"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-025-03035-z","article-title":"Multi-node inhibition targeting mTORC1, mTORC2 and PI3K\u03b1 potently inhibits the PI3K\/AKT\/mTOR pathway in endometrial and breast cancer models","volume":"133","author":"Tyrakis","year":"2025","journal-title":"Br J Cancer"},{"key":"B177","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0662","article-title":"The PI3K\/AKT\/mTOR pathway as a therapeutic target in endometrial cancer","volume":"18","author":"Slomovitz","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2142","article-title":"PI3K inhibition reduces mammary tumor growth and facilitates antitumor immunity and anti-PD1 responses","volume":"23","author":"Sai","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B180","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s12672-025-02169-z","article-title":"Immune microenvironment and molecular mechanisms in endometrial cancer: implications for resistance and innovative treatments","volume":"16","author":"Chen","year":"2025","journal-title":"Discov Oncol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ygyno.2023.08.007","article-title":"The spectrum of MAPK-ERK pathway genomic alterations in gynecologic Malignancies: Opportunities for novel therapeutic approaches","volume":"177","author":"Nasioudis","year":"2023","journal-title":"Gynecol Oncol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.01.024","article-title":"MAP kinase inhibition promotes T cell and anti-tumor activity in combination with PD-L1 checkpoint blockade","volume":"44","author":"Ebert","year":"2016","journal-title":"Immunity"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0118","article-title":"Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function","volume":"70","author":"Boni","year":"2010","journal-title":"Cancer Res"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28864","article-title":"The MAPK pathway across different Malignancies: a new perspective","volume":"120","author":"Burotto","year":"2014","journal-title":"Cancer"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-\u03baB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.03.002","article-title":"Molecular and clinical insights into early-onset endometrial cancer","volume":"11","author":"Wu","year":"2025","journal-title":"Trends Cancer"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092265","article-title":"Estrogens, cancer and immunity","volume":"14","author":"Orzo\u0142ek","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601975","article-title":"Estrogen signaling contributes to sex differences in macrophage polarization during asthma","volume":"199","author":"Keselman","year":"2017","journal-title":"J Immunol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1080\/09553002.2019.1589653","article-title":"The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression","volume":"95","author":"Vaupel","year":"2019","journal-title":"Int J Radiat Biol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumour microenvironments","volume":"21","author":"Vaupel","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B192","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab"},{"key":"B193","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110278","article-title":"HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J Exp Med"},{"key":"B195","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cmet.2018.06.021","article-title":"Dysfunction of natural killer cells by FBP1-induced inhibition of glycolysis during lung cancer progression","volume":"28","author":"Cong","year":"2018","journal-title":"Cell Metab"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02993","article-title":"New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages","volume":"10","author":"Batista-Gonzalez","year":"2019","journal-title":"Front Immunol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/eji.201445427","article-title":"Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal","volume":"46","author":"Mills","year":"2016","journal-title":"Eur J Immunol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1038\/s44319-023-00038-w","article-title":"Immunosurveillance encounters cancer metabolism","volume":"25","author":"Chuang","year":"2024","journal-title":"EMBO Rep"},{"key":"B199","doi-asserted-by":"publisher","first-page":"ra97","DOI":"10.1126\/scisignal.aab2610","article-title":"Glutamine-dependent \u03b1-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation","volume":"8","author":"Klysz","year":"2015","journal-title":"Sci Signal"},{"key":"B200","doi-asserted-by":"publisher","first-page":"109101","DOI":"10.1016\/j.celrep.2021.109101","article-title":"Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation","volume":"35","author":"Crump","year":"2021","journal-title":"Cell Rep"},{"key":"B201","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1038\/s41467-018-04719-2","article-title":"Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice","volume":"9","author":"Loftus","year":"2018","journal-title":"Nat Commun"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01565","article-title":"Immunoregulatory interplay between arginine and tryptophan metabolism in health and disease","volume":"10","author":"Mondanelli","year":"2019","journal-title":"Front Immunol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B204","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.immuni.2020.06.016","article-title":"An oncogenic alteration creates a microenvironment that promotes tumor progression by conferring a metabolic advantage to regulatory T cells","volume":"53","author":"Kumagai","year":"2020","journal-title":"Immunity"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.025","article-title":"ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis","volume":"161","author":"Cubillos-Ruiz","year":"2015","journal-title":"Cell"},{"key":"B206","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13148-024-01633-x","article-title":"The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications","volume":"16","author":"Zhu","year":"2024","journal-title":"Clin Epigenet"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.3390\/epigenomes9020018","article-title":"DNA methylation, aging, and cancer","volume":"9","author":"Vaidya","year":"2025","journal-title":"Epigenomes"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1012138","article-title":"ERBB2 promoter demethylation and immune cell infiltration promote a poor prognosis for cancer patients","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12964-024-01570-5","article-title":"Tumor-derived miR-6794-5p enhances cancer growth by promoting M2 macrophage polarization","volume":"22","author":"Choi","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-021-01027-6","article-title":"The impact of obesity and bariatric surgery on the immune microenvironment of the endometrium","volume":"46","author":"Naqvi","year":"2022","journal-title":"Int J Obes (Lond)"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34356","article-title":"Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancer","volume":"128","author":"Moukarzel","year":"2022","journal-title":"Cancer"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13237248","article-title":"Pilot data suggest that obesity and presence of Malignancy are associated with altered immune cell infiltration in endometrial biopsies","volume":"13","author":"Jacques","year":"2024","journal-title":"J Clin Med"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front Immunol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03458-1","article-title":"Immunometabolism of regulatory T cells in cancer","volume":"44","author":"Saravia","year":"2025","journal-title":"Oncogene"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.08.028","article-title":"Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma","volume":"135","author":"K\u00fcbler","year":"2014","journal-title":"Gynecologic Oncol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.3390\/cells14100741","article-title":"Tumor-associated macrophages: polarization, immunoregulation, and immunotherapy","volume":"14","author":"Saeed","year":"2025","journal-title":"Cells"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01232-z","article-title":"Targeting of TAMs: can we be more clever than cancer cells","volume":"21","author":"Kzhyshkowska","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-2376","article-title":"IgA-dominated humoral immune responses govern patients\u2019 Outcome in endometrial cancer","volume":"82","author":"Mandal","year":"2022","journal-title":"Cancer Res"},{"key":"B219","doi-asserted-by":"publisher","first-page":"e13249","DOI":"10.1111\/cpr.13249","article-title":"Single-cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer","volume":"55","author":"Yu","year":"2022","journal-title":"Cell Prolif"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1145300","article-title":"Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma","volume":"14","author":"Yu","year":"2023","journal-title":"Front Immunol"},{"key":"B221","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0002","article-title":"The interplay between extracellular matrix remodeling and cancer therapeutics","volume":"14","author":"Prakash","year":"2024","journal-title":"Cancer Discov"},{"key":"B223","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12916-021-02193-0","article-title":"Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis","volume":"20","author":"Bouras","year":"2022","journal-title":"BMC Med"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.3109\/10409238.2013.875514","article-title":"Interplay between DNA repair and inflammation, and the link to cancer","volume":"49","author":"Kidane","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081808","article-title":"Crosstalk between DNA damage and inflammation in the multiple steps of carcinogenesis","volume":"18","author":"Kawanishi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105756","article-title":"The role of microbiota in the immunopathogenesis of endometrial cancer","volume":"23","author":"Sobstyl","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-020-0286-z","article-title":"The microbiome and gynaecological cancer development, prevention and therapy","volume":"17","author":"\u0141aniewski","year":"2020","journal-title":"Nat Rev Urol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws309","article-title":"Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis","volume":"177","author":"Dossus","year":"2013","journal-title":"Am J Epidemiol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-10-0053","article-title":"Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study","volume":"17","author":"Dossus","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1689114","article-title":"Inflammation-driven mechanisms in endometrial cancer: pathways from inflammatory microenvironment remodeling to immune escape","volume":"16","author":"Tan","year":"2025","journal-title":"Front Immunol"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010066","article-title":"Modulation of tumor-associated macrophages to overcome immune suppression in the hepatocellular carcinoma microenvironment","volume":"17","author":"Singer","year":"2024","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1749138\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:32:24Z","timestamp":1770013944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1749138\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":231,"alternative-id":["10.3389\/fimmu.2026.1749138"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1749138","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"article-number":"1749138"}}